Another high-risk subtype, Philadelphia-like (Ph-like) ALL, lacks the BCR-ABL1 fusion but shares a similar gene expression profile and often harbors targetable kinase alterations involving ABL-class fusions or the JAK-STAT pathway [72]. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.